Pulmonology
mMRC Dyspnoea Scale
Breathlessness severity in COPD.
Education and reference only. Not a substitute for clinical judgement, local policy or product labelling. Always verify before clinical use. Values are calculated in your browser and never stored.
Background
The modified Medical Research Council (mMRC) dyspnoea scale grades the severity of breathlessness based on the level of activity that provokes it. It is a five-point scale from 0 (breathless only on strenuous exercise) to 4 (too breathless to leave the house or breathless when dressing). It is simple, patient-reported and reproducible, and is most commonly used in chronic obstructive pulmonary disease (COPD) as part of symptom assessment. It forms one component of the GOLD assessment of COPD, alongside symptom and exacerbation history.
Interpreting the result
Lower grades (0–1) indicate relatively preserved exercise tolerance, while a grade of 2 marks moderate breathlessness — walking slower than peers or stopping for breath on level ground. Grades 3–4 reflect severe limitation, with breathlessness after a short distance or even with basic tasks. In COPD, an mMRC grade of 2 or more is often taken as the threshold for “more symptomatic” when categorising patients and considering treatment. The scale captures the impact of breathlessness on daily life rather than measuring lung function directly.
Worked example
A patient with COPD says they have to walk more slowly than other people of the same age on level ground, and sometimes stop to catch their breath. This corresponds to mMRC grade 2 — moderate breathlessness — placing them in the more-symptomatic group for COPD assessment.
Pearls / pitfalls
- It measures the impact of breathlessness on activity, not lung function — a patient with severe airflow obstruction may report a low grade and vice versa.
- Use it consistently for the same patient over time to detect change; it is a useful longitudinal measure.
- Breathlessness has many causes (cardiac, anaemia, deconditioning) — a high grade is not specific to COPD.
- The CAT (COPD Assessment Test) is an alternative, broader symptom measure; the two are not interchangeable point-for-point.
Evidence & validation
The mMRC scale is derived from the original Medical Research Council breathlessness questionnaire and is endorsed within the GOLD strategy for COPD and by NICE for assessing breathlessness severity, where it complements spirometry and exacerbation history.
Frequently asked questions
What mMRC grade is considered significant in COPD?
A grade of 2 or more is commonly used as the threshold for being “more symptomatic” in COPD assessment. This influences how the patient is categorised and which treatments are considered.
Does mMRC measure lung function?
No. It grades the breathlessness a patient experiences during everyday activity, not the degree of airflow obstruction. Spirometry is needed to assess lung function, and the two can be discordant.
Can mMRC be used outside COPD?
Yes, it can grade exertional breathlessness from many causes, including heart failure and interstitial lung disease. It is most established in COPD but is a general measure of dyspnoea impact.
How does mMRC differ from the CAT score?
mMRC focuses solely on breathlessness, whereas the CAT is a broader questionnaire covering cough, sputum, chest tightness, activity and sleep. Both are used in COPD assessment but capture different aspects and are not directly interchangeable.
References
- Fletcher CM. Standardised questionnaire on respiratory symptoms (MRC breathlessness scale). BMJ. 1960.
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD.
Related calculators
Need a calculator we don't have — or a custom tool?
We build evidence-led clinical calculators, dashboards and reference tools for teams.